Source comparison
Adamax vs Semax Amidate: Research Application Comparison
Primary Receptor Target Melanocortin receptors (MC1R, MC3R, MC4R) Neurotrophic pathways (BDNF/TrkB signalling) Non-overlapping. Distinct biological systems Site of Action Peripheral tissues (adipose, muscle, adrenal glands) Central nervous system (hippocampus,
This comparison does not assign a generated winner or score.
- Primary Receptor Target
- Melanocortin receptors (MC1R, MC3R, MC4R)
- Neurotrophic pathways (BDNF/TrkB signalling)
- Non-overlapping. Distinct biological systems
- Site of Action
- Peripheral tissues (adipose, muscle, adrenal glands)
- Central nervous system (hippocampus, prefrontal cortex)
- Adamax = metabolic; Semax = cognitive
- Half-Life (Estimated)
- 45–90 minutes without modification
- 3–6 hours due to C-terminal amidation
- Semax Amidate requires less frequent dosing
- Blood-Brain Barrier Penetration
- Minimal. Designed for peripheral action
- High. Optimised for CNS delivery
- Critical difference for cognitive research
- Research Use Case
- Energy expenditure, stress adaptation, appetite regulation studies
- Neuroprotection, memory consolidation, stroke recovery models
- Choose based on tissue system being studied
- Shelf Stability (Lyophilised)
- Stable at −20°C for 24+ months
- Both require reconstitution with bacteriostatic water
- Adamax fits metabolic research protocols examining cortisol dynamics, thermogenic responses, or appetite modulation. Semax Amidate fits neurocognitive studies examining learning, neuroplasticity, or neuroprotective interventions. Selecting between them isn't a preference. It's dictated by the biological system your research targets.